WallStSmart

Healthpeak Properties Inc (DOC)vsVentas Inc (VTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ventas Inc generates 117% more annual revenue ($6.11B vs $2.82B). VTR leads profitability with a 4.3% profit margin vs 2.5%. VTR appears more attractively valued with a PEG of 1.72. DOC earns a higher WallStSmart Score of 54/100 (C-).

DOC

Buy

54

out of 100

Grade: C-

Growth: 7.3Profit: 5.0Value: 4.7Quality: 3.5
Piotroski: 2/9Altman Z: 0.24

VTR

Buy

51

out of 100

Grade: C-

Growth: 7.3Profit: 4.5Value: 4.0Quality: 3.8
Piotroski: 4/9Altman Z: 0.39
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DOCUndervalued (+45.0%)

Margin of Safety

+45.0%

Fair Value

$30.85

Current Price

$16.42

$14.43 discount

UndervaluedFair: $30.85Overvalued
VTRUndervalued (+4.8%)

Margin of Safety

+4.8%

Fair Value

$90.03

Current Price

$88.02

$2.01 discount

UndervaluedFair: $90.03Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DOC3 strengths · Avg: 8.7/10
EPS GrowthGrowth
2448.0%10/10

Earnings expanding 2448.0% YoY

Price/BookValuation
1.5x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.1%8/10

Strong operational efficiency at 20.1%

VTR1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
21.9%8/10

Revenue surging 21.9% year-over-year

Areas to Watch

DOC4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
3.1%4/10

3.1% revenue growth

Return on EquityProfitability
1.2%3/10

ROE of 1.2% — below average capital efficiency

Profit MarginProfitability
2.5%3/10

2.5% margin — thin

Debt/EquityHealth
1.393/10

Elevated debt levels

VTR4 concerns · Avg: 3.0/10
PEG RatioValuation
1.724/10

Expensive relative to growth rate

Return on EquityProfitability
2.1%3/10

ROE of 2.1% — below average capital efficiency

Profit MarginProfitability
4.3%3/10

4.3% margin — thin

P/E RatioValuation
160.0x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : DOC

The strongest argument for DOC centers on EPS Growth, Price/Book, Operating Margin.

Bull Case : VTR

The strongest argument for VTR centers on Revenue Growth. Revenue growth of 21.9% demonstrates continued momentum.

Bear Case : DOC

The primary concerns for DOC are Revenue Growth, Return on Equity, Profit Margin. A P/E of 164.2x leaves little room for execution misses. Thin 2.5% margins leave little buffer for downturns.

Bear Case : VTR

The primary concerns for VTR are PEG Ratio, Return on Equity, Profit Margin. A P/E of 160.0x leaves little room for execution misses. Thin 4.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

DOC profiles as a value stock while VTR is a growth play — different risk/reward profiles.

DOC carries more volatility with a beta of 1.08 — expect wider price swings.

VTR is growing revenue faster at 21.9% — sustainability is the question.

DOC generates stronger free cash flow (242M), providing more financial flexibility.

Bottom Line

DOC scores higher overall (54/100 vs 51/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Healthpeak Properties Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are rented to physicians, hospitals and healthcare delivery systems.

Visit Website →

Ventas Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.

Want to dig deeper into these stocks?